These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35179806)
1. Research on the synthesis of nanoparticles of betulinic acid and their targeting antitumor activity. Chen X; Lu S; Gong F; Sui X; Liu T; Wang T J Biomed Mater Res B Appl Biomater; 2022 Aug; 110(8):1789-1795. PubMed ID: 35179806 [TBL] [Abstract][Full Text] [Related]
2. Antitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomes. Liu Y; Gao D; Zhang X; Liu Z; Dai K; Ji B; Wang Q; Luo L Mater Sci Eng C Mater Biol Appl; 2016 Jul; 64():124-132. PubMed ID: 27127036 [TBL] [Abstract][Full Text] [Related]
3. Thermosensitive Betulinic Acid-Loaded Magnetoliposomes: A Promising Antitumor Potential for Highly Aggressive Human Breast Adenocarcinoma Cells Under Hyperthermic Conditions. Farcas CG; Dehelean C; Pinzaru IA; Mioc M; Socoliuc V; Moaca EA; Avram S; Ghiulai R; Coricovac D; Pavel I; Alla PK; Cretu OM; Soica C; Loghin F Int J Nanomedicine; 2020; 15():8175-8200. PubMed ID: 33122905 [TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888 [TBL] [Abstract][Full Text] [Related]
5. EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment. Dutta D; Al Hoque A; Paul B; Park JH; Chowdhury C; Quadir M; Banerjee S; Choudhury A; Laha S; Sepay N; Boro P; Kaipparettu BA; Mukherjee B J Biomed Sci; 2024 Aug; 31(1):81. PubMed ID: 39164686 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate. Saneja A; Sharma L; Dubey RD; Mintoo MJ; Singh A; Kumar A; Sangwan PL; Tasaduq SA; Singh G; Mondhe DM; Gupta PN Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():616-626. PubMed ID: 28183653 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic applications of betulinic acid nanoformulations. Saneja A; Arora D; Kumar R; Dubey RD; Panda AK; Gupta PN Ann N Y Acad Sci; 2018 Jun; 1421(1):5-18. PubMed ID: 29377164 [TBL] [Abstract][Full Text] [Related]
8. Betulinic Acid and its Derivatives as Potential Antitumor Agents. Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847 [TBL] [Abstract][Full Text] [Related]
9. Targeting Effect of Betulinic Acid Liposome Modified by Hyaluronic Acid on Hepatoma Cells In Vitro. Wu X; Wei Z; Feng H; Chen H; Xie J; Huang Y; Wang M; Yao C; Huang J J Pharm Sci; 2022 Nov; 111(11):3047-3053. PubMed ID: 35779664 [TBL] [Abstract][Full Text] [Related]
10. Recent progress on betulinic acid and its derivatives as antitumor agents: a mini review. Zhong Y; Liang N; Liu Y; Cheng MS Chin J Nat Med; 2021 Sep; 19(9):641-647. PubMed ID: 34561074 [TBL] [Abstract][Full Text] [Related]
11. A Novel Betulinic Acid Analogue: Synthesis, Solubility, Antitumor Activity and Pharmacokinetic Study in Rats. Liang Y; Zhu M; Xu T; Ding W; Chen M; Wang Y; Zheng J Molecules; 2023 Jul; 28(15):. PubMed ID: 37570685 [TBL] [Abstract][Full Text] [Related]
12. Eudragit S100 prepared pH-responsive liposomes-loaded betulinic acid against colorectal cancer Wang G; Yang Y; Yi D; Yuan L; Yin PH; Ke X; Jun-Jie W; Tao MF J Liposome Res; 2022 Sep; 32(3):250-264. PubMed ID: 34895013 [TBL] [Abstract][Full Text] [Related]
13. Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique. Li S; Zhang J; Fang Y; Yi J; Lu Z; Chen Y; Guo B Drug Des Devel Ther; 2020; 14():243-256. PubMed ID: 32021108 [TBL] [Abstract][Full Text] [Related]
14. Targeting mitochondrial apoptosis by betulinic acid in human cancers. Fulda S; Kroemer G Drug Discov Today; 2009 Sep; 14(17-18):885-90. PubMed ID: 19520182 [TBL] [Abstract][Full Text] [Related]
15. Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments. Valdés K; Morales J; Rodríguez L; Günther G Nanomedicine (Lond); 2016 Dec; 11(23):3139-3156. PubMed ID: 27809705 [TBL] [Abstract][Full Text] [Related]
16. Gold nanoshell-based betulinic acid liposomes for synergistic chemo-photothermal therapy. Liu Y; Zhang X; Liu Z; Wang L; Luo L; Wang M; Wang Q; Gao D Nanomedicine; 2017 Aug; 13(6):1891-1900. PubMed ID: 28363771 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, Characterization of Liposomes Modified with Biosurfactant MEL-A Loading Betulinic Acid and Its Anticancer Effect in HepG2 Cell. Shu Q; Wu J; Chen Q Molecules; 2019 Oct; 24(21):. PubMed ID: 31683639 [TBL] [Abstract][Full Text] [Related]
18. Betulinic acid triggers apoptosis and inhibits migration and invasion of gastric cancer cells by impairing EMT progress. Chen Y; Wu X; Liu C; Zhou Y Cell Biochem Funct; 2020 Aug; 38(6):702-709. PubMed ID: 32283563 [TBL] [Abstract][Full Text] [Related]
19. [Synthesis of betulinic acid from betulin and study of its solubilization usingliposomes]. Son LB; Kaplun AP; Spilevskiĭ AA; Andiia-Pravdivyĭ IuE; Alekseeva SG; Gribor'ev VB; Shvets VI Bioorg Khim; 1998 Oct; 24(10):787-93. PubMed ID: 9929738 [TBL] [Abstract][Full Text] [Related]
20. Betulinic acid in the treatment of breast cancer: Application and mechanism progress. Mu H; Sun Y; Yuan B; Wang Y Fitoterapia; 2023 Sep; 169():105617. PubMed ID: 37479118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]